Results 11 to 20 of about 46,160 (296)
Altered brainstem responses to modafinil in schizophrenia: implications for adjunctive treatment of cognition. [PDF]
, 2018 Candidate pro-cognitive drugs for schizophrenia targeting several neurochemical systems have consistently failed to demonstrate robust efficacy. It remains untested whether concurrent antipsychotic medications exert pharmacodynamic interactions that ...
Carter, Cameron S +3 more
core +3 more sources
Communications Medicine, 2023 Background Preclinical evidence suggests that certain antipsychotic medications may inhibit the development of lung cancer. This study aims to investigate the association between incident lung cancer and different cumulative exposure periods of ...
Yi Chai +10 more
doaj +1 more source
Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A meta-analysis of randomised controlled treatment trials [PDF]
, 2006 Small studies have shown positive effects from adding a variety of antipsychotic agents in patients with obsessive–compulsive disorder who are unresponsive to treatment with serotonin reuptake inhibitors. The evidence, however, is contradictory.
Carey, P +8 more
core +1 more source
Pancreatitis following Olanzapine Therapy: A Report of Three Cases [PDF]
, 2007 CONTEXT: Atypical antipsychotic agents (clozapine, olanzapine) have been linked to metabolic effects and acute pancreatitis. CASE REPORT: We reviewed the inpatient and outpatient records of three patients who developed acute pancreatitis while being ...
Azar, Riad +3 more
core +4 more sources
Pharmaceuticals, 2010 Antidepressant therapies, such as selective serotonin reuptake inhibitors (SSRIs), are current first-line treatments for Major Depressive Disorder. However, over 50% of treated patients show an inadequate response to initial antidepressant therapy.
Allan H. Young +2 more
doaj +1 more source
Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
Neuropsychopharmacology Reports, 2020 Ichihashi et al reported that 43% of patients had antipsychotic polypharmacy. Number of antipsychotics used in patients with schizophrenia in Japan was the greatest among Asian countries.
Norio Yasui‐Furukori, Kazutaka Shimoda
doaj +1 more source
Combination treatments in schizophrenia
Psychiatry and Clinical Psychopharmacology, 2021 Use of multiple antipsychotic agents in patients with schizophrenia, especially in treatment resistant schizophrenia, is common practice in psychiatry, although most schizophrenia guidelines recommend monotherapy.
Vesile Altınyazar, Nevzat Yüksel
doaj +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Kaohsiung Journal of Medical Sciences, 2005 Few studies have directly compared atypical antipsychotics (e.g. risperidone) with typical antipsychotics as adjunctive therapy in patients hospitalized for acute mania, especially during a lengthy hospital stay.
Jui-Hsiu Tsai, Ju-Yu Yen
doaj +1 more source
Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain. [PDF]
PLoS ONE, 2015 Various types of antipsychotics have been developed for the treatment of schizophrenia since the accidental discovery of the antipsychotic activity of chlorpromazine.
Kensuke Sakuma +5 more
doaj +1 more source